Free Trial

Citadel Advisors LLC Invests $54,000 in Carmell Co. (NASDAQ:CTCX)

Carmell logo with Medical background

Citadel Advisors LLC purchased a new stake in shares of Carmell Co. (NASDAQ:CTCX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 187,565 shares of the company's stock, valued at approximately $54,000. Citadel Advisors LLC owned 0.90% of Carmell at the end of the most recent quarter.

Separately, Antara Capital LP acquired a new stake in shares of Carmell during the 4th quarter worth approximately $28,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Carmell Price Performance

CTCX stock traded down $0.04 during trading on Friday, hitting $2.60. The company had a trading volume of 23,813 shares, compared to its average volume of 4,006,984. The company has a fifty day moving average price of $1.39 and a two-hundred day moving average price of $0.68. Carmell Co. has a fifty-two week low of $0.17 and a fifty-two week high of $2.06.

About Carmell

(Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Recommended Stories

Should You Invest $1,000 in Carmell Right Now?

Before you consider Carmell, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.

While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines